Table: begin end state 1 20 cytoplasmic 21 47 transmembrane 48 62 non-cytoplasmic 63 83 transmembrane 84 90 cytoplasmic 91 110 transmembrane 111 115 non-cytoplasmic 116 137 transmembrane 138 149 cytoplasmic 150 169 transmembrane 170 178 non-cytoplasmic 179 198 transmembrane 199 257 cytoplasmic 258 281 transmembrane 282 296 non-cytoplasmic 297 318 transmembrane 319 328 cytoplasmic 329 348 transmembrane 349 359 non-cytoplasmic 360 384 transmembrane 385 403 cytoplasmic 404 422 transmembrane 423 427 non-cytoplasmic 428 446 transmembrane 447 473 cytoplasmic
Input: >WP_008806353.1 NCBI__GCF_000025465.1:WP_008806353.1 MTSISNDSALTPRTQRDTRRMNWFVSIAAAVAGLLFGLDIGVISGALPFITDHFTLSSQL QEWVVSSMMLGAAIGALFNGWLSFRLGRKYSLMAGAVLFVAGSIGSAFAASVEVLLIARV VLGVAVGIASYTAPLYLSEMASENVRGKMISMYQLMVTLGIVLAFLSDTAFSYSGNWRAM LGVLALPAVILIILVVFLPNSPRWLAEKGRHIEAEEVLRMLRDTSEKARDELNEIRESLK LKQGGWALFKVNRNVRRAVFLGMLLQAMQQFTGMNIIMYYAPRIFKMAGFTTTEQQMIAT LVVGLTFMFATFIAVFTVDKAGRKPALKIGFSVMALGTLVLGYCLMQFDNGTASSGLSWL SVGMTMMCIAGYAMSAAPVVWILCSEIQPLKCRDFGITCSTTTNWVSNMIIGATFLTLLD AIGAAGTFWLYTVLNVAFIGVTFWLIPETKNVTLEHIERNLMAGEKLRNIGNR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server